Skip to main content
. 2021 Mar 29;12:647369. doi: 10.3389/fendo.2021.647369

Table 2.

Post-hoc test after Kruskal-Wallis analysis for median circulating miR-375 levels in the different groups: group 0: healthy subjects, group 1: MTC patients, group 2: patients with thyroid non-C-cell nodular diseases (non-CTN), group 3: pheochromocytoma patients.

Factor n Average Rank Different (P < 0.05) from factor nr
0 (healthy subjects) 19 69.40 (1)(2)(3)
1 (MTC) 69 116.17 (0)(2)(3)
2 (non-CTN) 49 40.43 (0)(1)(3)
3 (pheochromocytoma) 14 17.36 (0)(1)(2)